Dihydromyricetin Modulates Nrf2 and NF-κB Crosstalk to Alleviate Methotrexate-Induced Lung Toxicity
Open Access
- 23 March 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (4) , 481
Abstract
Background: Methotrexate (MTX) is an effective anticancer, anti-inflammatory, and immunomodulatory agent. However, it induces a serious pneumonitis that leads to irreversible fibrotic lung damage. This study addresses the protective role of the natural flavonoid dihydromyricetin (DHM) against MTX-induced pneumonitis via modulation of Nrf2/NF-κB signaling crosstalk. Methods: Male Wistar rats were divided into 4 groups: control, which received the vehicle; MTX, which received a single MTX (40 mg/kg, i.p) at day 9 of the experiment; (MTX + DHM), which received oral DHM (300 mg/kg) for 14 days and methotrexate (40 mg/kg, i.p) on the 9th day; and DHM, which received DHM (300 mg/kg, p.o) for 14 days. Results: Lung histopathological examination and scoring showed a decline in MTX-induced alveolar epithelial damage and decreased inflammatory cell infiltration by DHM treatment. Further, DHM significantly alleviated the oxidative stress by decreasing MDA while increasing GSH and SOD antioxidant levels. Additionally, DHM suppressed the pulmonary inflammation and fibrosis through decreasing levels of NF-κB, IL-1β, and TGF-β1 while promoting the expression of Nrf2, a positive regulator of antioxidant genes, and its downstream modulator, HO-1. Conclusion: This study identified DHM as a promising therapeutic target against MTX-induced pneumonitis via activation of Nrf2 antioxidant signaling while suppressing the NF-κB mediated inflammatory pathways.Keywords
This publication has 95 references indexed in Scilit:
- Dihydromyricetin As a Novel Anti-Alcohol Intoxication MedicationJournal of Neuroscience, 2012
- Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathwayToxicology, 2009
- Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intakeAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Variation of immunological response in methotrexate-induced pneumonitisRheumatology, 2008
- Molecular mechanisms of Nrf2‐mediated antioxidant responseMolecular Carcinogenesis, 2008
- Disruption of Nrf2 Enhances Upregulation of Nuclear Factor‐κB Activity, Proinflammatory Cytokines, and Intercellular Adhesion Molecule‐1 in the Brain after Traumatic Brain InjuryMediators of Inflammation, 2008
- Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid ArthritisPharmacological Reviews, 2005
- Toward a better understanding of methotrexateArthritis & Rheumatism, 2004
- Oxidative stress contributes to methotrexate-induced small intestinal toxicity in ratsScandinavian Journal of Gastroenterology, 2004
- NF-κB: a key role in inflammatory diseasesJournal of Clinical Investigation, 2001